Anil Kumar Sah
Overview
Explore the profile of Anil Kumar Sah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yadav P, Shrestha S, Basyal D, Tiwari A, Sah R, Sah A, et al.
Int J Microbiol
. 2025 Jan;
2024:5749982.
PMID: 39758150
Multidrug-resistant (MDR) poses a significant therapeutic challenge due to its resistance to multiple antibiotics and its ability to form biofilm. This study aimed to characterize MDR isolates for their biofilm-forming...
2.
Oli P, Poudel P, Kc S, Kc A, Sah A, Yadav P
Ann Med Surg (Lond)
. 2024 Jun;
86(6):3663-3666.
PMID: 38846898
Introduction And Importance: The SARS-CoV-2 is the source of COVID-19, a respiratory disease. It typically manifests as restricted pulmonary symptoms, but autoimmune dysfunction might occasionally show up. A COVID-19 infection...
3.
Sah U, Sah A, Ansari M, Chaudhary P, Gupta S, Kumar P, et al.
Trop Med Infect Dis
. 2023 Jul;
8(7).
PMID: 37505657
Hepatitis C Virus (HCV) co-infection and its genotypic distribution in people living with Human Immunodeficiency Virus (HIV) show global inconsistency. Therefore, the present study aimed to investigate the prevalence and...
4.
Neupane L, Sah A, Rayamajhee B, Pokhrel A, Singh A
J Nepal Health Res Counc
. 2023 Jul;
20(4):899-905.
PMID: 37489674
Background: Antibiotic resistance is a great concern for public health and Acinetobacter baumannii-associated infections are increasing in many parts of the world, including Nepal. However, limited data is available on...
5.
Thapa A, Upreti M, Bimali N, Shrestha B, Sah A, Nepal K, et al.
Infect Drug Resist
. 2022 Aug;
15:4419-4434.
PMID: 35983298
Background: Increasing burden of carbapenem resistance among is attributable to their ability to produce carbapenemase enzymes like metallo-beta-lactamase (MBL), carbapenemase (KPC), and OXA-type. This study aimed to determine the prevalence...
6.
Sah A, Maharjan B, Adhikari M, Rana R, Basnet S, Panta R, et al.
JNMA J Nepal Med Assoc
. 2022 Feb;
59(242):1069-1071.
PMID: 35199706
Herniation of bladder mucosa through the bladder wall muscle layer is known as bladder diverticulum. The incidence of bladder diverticulum is 1.7. About 0.8 to 10% of the urinary bladder...
7.
Maharjan M, Sah A, Pyakurel S, Thapa S, Maharjan S, Adhikari N, et al.
Int J Microbiol
. 2021 Dec;
2021:3847347.
PMID: 34899917
, a commensal on the skin and in the nasal cavity of humans, is one of the most serious cases of nosocomial infections. Moreover, methicillin-resistant (MRSA) is a leading cause...
8.
Pyakurel S, Ansari M, Kattel S, Rai G, Shrestha P, Rai K, et al.
Trop Med Health
. 2021 Sep;
49(1):78.
PMID: 34565485
Aim: Although carbapenem is the last-resort drug for treating drug-resistant Gram-negative bacterial infections, prevalence of carbapenem-resistant bacteria has substantially increased worldwide owing to irrational use of antibiotics particularly in developing...
9.
Ansari M, Aryal S, Rai G, Rai K, Pyakurel S, Bhandari B, et al.
Iran J Microbiol
. 2021 Sep;
13(3):303-311.
PMID: 34540168
Background And Objectives: Carbapenems have been the choice of antibiotics for the treatment of infections caused by multidrug-resistant bacteria. The main objective of this study was to determine the prevalence...
10.
Ghimire N, Vaidya A, Sah A, Karakheti A, Rana K, Malla P, et al.
J Nepal Health Res Counc
. 2021 Jan;
18(4):714-718.
PMID: 33510516
Background: The characteristics of research proposals submitted to the Nepal Health Research Council reflect the trend of health-related researches being conducted in Nepal. The objective of the study was to...